Avantor Inc (NYSE:AVTRpA.PFD)
$ 90.81 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 50.60 PB Ratio: 2.79 GF Score: 76/100

Avantor Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 05:45PM GMT
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Hi, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at JPMorgan. Today, I'm joined by Michael Stubblefield and Tom Szlosek, CEO and CFO of Avantor. So today, this will be -- the first part will be presentation. The second half will be Q&A-based. We have mic runners throughout the room. So you either can ask a question in person. Or for those of you listening live on the webcast online, you can submit Q&A through the portal. Michael, with that, why don't you take it off?

Michael Stubblefield
Avantor, Inc. - President, CEO & Director

Excellent. Thank you, Rachel, and good morning, everyone. It's really great to be back here in San Francisco to kick off a new year with all the sunny weather that we're enjoying here in town. But certainly appreciate you joining us for our presentation today. As Rachel mentioned, I'm joined on the stand here by Tom Szlosek, our CFO; and Christina Jones, our Vice President of Investor Relations is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot